Purified recombinant Human ApoSAA1 protein Expression System: E.coli Bioactivity: For most in vitro applications, apo-SAA exerts its biological activity in the concentration range of 10-50 µg/mL.
Human apo-SAA is a 104 amino acid polypeptide that circulates primarily in association with high-density lipoproteins (HDL). The level of apo-SAA, normally 1-5 ug/ml in plasma, increases 500-1000 fold within 24 hours of an inflammatory stimulus and, under these conditions, is the most abundant HDL apo-lipoprotein. The human SAA gene codes for a 122 amino acid polypeptide, which contains an 18 amino acid N-terminal signal sequence. Recombinant Apo-SAA is a consensus SAA molecule corresponding to human apo-SAA1alpha. Alternative Names: ApoSAA-1 protein, Human Serum Amyloid A protein, ApoSAA-1 protein, ApoSAA1, ApoSAA-1, ApoSAA 1 protein, ApoSAA 1